ACP
VIVE

Acuta Capital Partners’s VIVEVE MED INC VIVE Stock Holding History

Acuta Capital Partners’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-268
Closed -$728K – 55
2018
Q2 		$728K Sell
268
-417
-61% -$1.2M 0.13% 52
2018
Q1 		$2.51M Buy
685
+252
+58% +$1.1M 0.41% 33
2017
Q4 		$2.15M Sell
433
-394
-48% -$2.05M 0.41% 34
2017
Q3 		$4.33M Buy
827
+117
+16% +$721K 0.78% 29
2017
Q2 		$5.1M Sell
710
-430
-38% -$3.21M 1.43% 18
2017
Q1 		$7.22M Buy
+1,140
New +$5.55M 1.71% 15

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acuta Capital Partners's VIVE Position: Q3 2018 in Review

Acuta Capital Partners sold out of VIVEVE MED INC (VIVE) in Q3 2018, closing a stake of 268 shares — an estimated $728K sold.

Acuta Capital Partners first reported a position in VIVE in Q1 2017 and held it in 6 quarters. The position peaked at $7.22M in Q1 2017. 36 funds tracked by Wall St. Rank hold VIVE as of Q3 2018.

  • Acuta Capital Partners reported no remaining VIVEVE MED INC position as of Q3 2018 after selling out during the quarter.
  • Acuta Capital Partners sold 268 VIVEVE MED INC shares in Q3 2018, an estimated $728K.
  • Acuta Capital Partners first reported a position in VIVEVE MED INC in Q1 2017 and held it in 6 quarters.
  • Acuta Capital Partners's VIVEVE MED INC position peaked at $7.22M in Q1 2017.
  • 36 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2018.

Based on Acuta Capital Partners's 13F filing for Q3 2018, filed 7 Nov 2018.